Search Results - "Reyes, Jheremy"
-
1
Bloodstream Infections in Adult Patients Undergoing Cord Blood Transplantation from Unrelated Donors after Myeloablative Conditioning Regimen
Published in Biology of blood and marrow transplantation (01-04-2015)“…Abstract The incidence, epidemiology, and risk factors of bloodstream infection (BSI) and their impact on transplant outcomes after umbilical cord blood…”
Get full text
Journal Article -
2
Criterios de respuesta para definir éxito en la terapia de pacientes hemofílicos llevados a cirugía: Revisión ampliada de la literatura (RAL)
Published in Repertorio de medicina y cirugía (01-03-2015)“…La hemofilia, enfermedad congénita de baja prevalencia en la población general, se clasifica en tipos A y B según su deficiencia sea del factor VIII o IX de la…”
Get full text
Journal Article -
3
PB1870: FACTORS ASSOCIATED WITH OVERALL SURVIVAL IN ACUTE MYELOID LEUKEMIA: RENEHOC REGISTRY STUDY
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
4
Clinical Features and Prognostic Factors in Multiple Myeloma Patients from Colombia. Real-World Data from Renehoc Registry
Published in Blood (02-11-2023)“…Background: The prognosis for patients with multiple myeloma (MM) has improved over time, but there is considerable heterogeneity in disease outcomes…”
Get full text
Journal Article -
5
Comparison of the Revised 4 Th (2016) and 5 Th (2022) Editions of the World Health Organization (WHO) Classification in a Cohort of Patients with Lower-Risk Myelodysplastic Syndromes/Neoplasms (MDS) - a Glam Registry (REGLAM) Analysis
Published in Blood (02-11-2023)“…Background: The5 th (2022) edition of the WHO Classification for MDS recognizes MDS patients into two groups: MDS with defining genetic abnormalities and MDS…”
Get full text
Journal Article -
6
POSTER: AML-581 Factors Associated With Survival in Secondary Acute Myeloid Leukemia in Colombia
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)Get full text
Journal Article -
7
AML-581 Factors Associated With Survival in Secondary Acute Myeloid Leukemia in Colombia
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)“…The management of secondary acute myeloid leukemia (s-AML) is challenging because its characteristics predict a poor prognosis. In Colombia, there is a paucity…”
Get full text
Journal Article -
8
Outcomes after First Rescue Treatment in Patients with Relapsed or Refractory Multiple Myeloma in Colombia
Published in Blood (23-11-2021)“…Background Proteasome inhibitors (PIs) are approved for treating newly diagnosed and relapsed multiple myeloma (MM) in Colombia. This propensity score matching…”
Get full text
Journal Article -
9
The Status of Multiple Myeloma in Colombia: First Report of the Colombian Registry for Hemato-Oncological Diseases (RENEHOC). Asociacion Colombiana De Hematologia y Oncologia (ACHO)
Published in Blood (29-11-2018)“…Introduction Multiple myeloma (MM) has characteristics that influence the prognosis and are useful to make decisions regarding treatment. Diagnosis and…”
Get full text
Journal Article -
10
-
11
CML-431 Second Line Treatment With Tyrosine Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) in Colombia. Report of the RENEHOC-ACHO Investigators
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)“…TKIs have changed the history of CML, achieving a life expectancy similar to that of the general population. However, a significant percentage of patients will…”
Get full text
Journal Article -
12
CML-252: Current Patient Management and Outcomes of Chronic Myeloid Leukemia (CML) in Colombia: On Behalf of ACHO’s RENEHOC Investigators
Published in Clinical lymphoma, myeloma and leukemia (01-09-2021)“…Tyrosine kinase inhibitors (TKIs) dramatically changed outcomes in CML; achieving and maintaining treatment milestones is highly dependent on adherence…”
Get full text
Journal Article -
13
-
14
CML-319: Impact of Insurance Differences in Outcomes in Colombian Patients with Chronic Myeloid Leukemia (CML)
Published in Clinical lymphoma, myeloma and leukemia (01-09-2020)“…Adherence is a key factor for good outcomes in CML. There are two types of insurance in Colombia: Contributory (CS) and Subsidized Systems (SS), which provide…”
Get full text
Journal Article -
15
Myelodysplastic syndromes in Latin America: state of the art
Published in Blood advances (30-11-2018)Get full text
Journal Article -
16
Multiple Myeloma Multicenter Registry in Colombia: The Impact of Autologous Stem Transplantation on Overall and Disease-Free Survival
Published in Blood (05-11-2020)“…Aim: RENEHOC (Registro Epidemiológico de Neoplasias Hematológicas en Colombia) is a multicenter clinical quality database established in January 2018. The…”
Get full text
Journal Article -
17
Impact of Sociodemographic and Clinical Factors on the Survival of Patients with Acute Myeloid Leukemia: A Multicenter Experience in Colombia, on Behalf of Acho's Renehoc-Pethema Investigators
Published in Blood (23-11-2021)“…Introduction: Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults, accounting for almost 80 percent of the cases. Incidence of AML…”
Get full text
Journal Article -
18
AML-425: Acute Myeloid Leukemia: A Multicenter Experience in Colombia, on behalf of ACHO’s RENEHOC Investigators
Published in Clinical lymphoma, myeloma and leukemia (01-09-2021)“…Our aim was to characterize the population of patients diagnosed with AML who were attended in 7 health institutions in Colombia, from 2009 to 2020, included…”
Get full text
Journal Article -
19
Poster: AML-425: Acute Myeloid Leukemia: A Multicenter Experience in Colombia, on behalf of ACHO’s RENEHOC Investigators
Published in Clinical lymphoma, myeloma and leukemia (01-09-2021)Get full text
Journal Article